关注
Fabrizio Chegai
Fabrizio Chegai
Radiology Resident, Department of Diagnostic and Molecular Imaging, Radiation Therapy and
在 asl.vt.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Hepatocellular carcinoma and diffusion-weighted MRI: detection and evaluation of treatment response
JS Gluskin, F Chegai, S Monti, E Squillaci, L Mannelli
Journal of Cancer 7 (11), 1565, 2016
782016
Kidney transplant: usefulness of real-time elastography (RTE) in the diagnosis of graft interstitial fibrosis
A Orlacchio, F Chegai, C Del Giudice, A Anselmo, G Iaria, G Palmieri, ...
Ultrasound in medicine & biology 40 (11), 2564-2572, 2014
662014
DWI of Prostate Cancer: Optimal b‐Value in Clinical Practice
G Manenti, M Nezzo, F Chegai, E Vasili, E Bonanno, G Simonetti
Prostate Cancer 2014 (1), 868269, 2014
492014
Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo …
A Orlacchio, F Chegai, S Merolla, S Francioso, C Del Giudice, M Angelico, ...
World Journal of Hepatology 7 (12), 1694, 2015
382015
Comparative evaluation of percutaneous laser and radiofrequency ablation in patients with HCC smaller than 4 cm
A Orlacchio, F Bolacchi, F Chegai, A Bergamini, E Costanzo, ...
La radiologia medica 119, 298-308, 2014
372014
Degradable starch microspheres transarterial chemoembolization (DSMs-TACE) in patients with unresectable hepatocellular carcinoma (HCC): long-term results from a single-center …
A Orlacchio, F Chegai, S Roma, S Merolla, A Bosa, S Francioso
La radiologia medica 125, 98-106, 2020
342020
Pattern of macrovascular invasion in hepatocellular carcinoma
M Guarino, A Cucchetti, G Pontillo, F Farinati, F Benevento, GL Rapaccini, ...
European Journal of Clinical Investigation 51 (7), e13542, 2021
222021
Evaluation of Contrast‐Enhanced Intraoperative Ultrasound in the Detection and Management of Liver Lesions in Patients with Hepatocellular Carcinoma
C Pace, V Nardone, S Roma, F Chegai, L Toti, TM Manzia, G Tisone, ...
Journal of oncology 2019 (1), 6089340, 2019
212019
Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers
A Orlacchio, F Chegai, S Fabiano, S Merolla, V Funel, F Di Giuliano, ...
La radiologia medica 121, 588-596, 2016
212016
Repeated transarterial chemoembolization with degradable starch microspheres (DSMs-TACE) of unresectable hepatocellular carcinoma: a prospective pilot study
A Orlacchio, F Chegai, S Francioso, S Merolla, S Monti, M Angelico, ...
Current Medical Imaging 14 (4), 637-645, 2018
192018
Foot embolization during limb salvage procedures in critical limb ischemia patients successfully managed with mechanical thromboaspiration: a technical note
R Gandini, S Merolla, F Chegai, C Del Giudice, M Stefanini, E Pampana
Journal of Endovascular Therapy 22 (4), 558-563, 2015
192015
Trans-splenic embolization plus partial splenic embolization for management of variceal bleeding due to left-sided portal hypertension
R Gandini, S Merolla, F Chegai, S Abrignani, I Lenci, M Milana, ...
Digestive Diseases and Sciences 63, 264-267, 2018
142018
Monofocal hepatocellular carcinoma: How much does size matter?
F Pelizzaro, B Penzo, G Peserico, A Imondi, A Sartori, A Vitale, U Cillo, ...
Liver International 41 (2), 396-407, 2021
132021
Intermediate hepatocellular carcinoma: the role of transarterial therapy
F Chegai, A Orlacchio, S Merolla, S Monti, L Mannelli
Hepatic oncology 2 (4), 399-408, 2015
132015
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors
B Stefanini, L Bucci, V Santi, N Reggidori, D Rampoldi, L Lani, A Granito, ...
Digestive and Liver Disease 54 (11), 1563-1572, 2022
122022
Radiofrequency thermoablation of HCC larger than 3 cm and less than 5 cm proximal to the gallbladder without gallbladder isolation: a single center experience
A Orlacchio, F Chegai, C Del Giudice, M Massaccesi, E Costanzo, ...
BioMed research international 2014 (1), 896527, 2014
112014
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs
N Reggidori, L Bucci, V Santi, B Stefanini, L Lani, D Rampoldi, G Ghittoni, ...
JHEP Reports 5 (8), 100784, 2023
92023
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma
EG Giannini, G Pieri, S Labanca, MCP Torres, A Gasbarrini, E Biasini, ...
Digestive and Liver Disease 54 (9), 1215-1221, 2022
82022
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment
A Cucchetti, A Gramenzi, P Johnson, EG Giannini, F Tovoli, GL Rapaccini, ...
European Journal of Cancer 158, 133-143, 2021
82021
Predictors of non‐transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection
F Pelizzaro, F Trevisani, V Simeon, A Vitale, U Cillo, F Piscaglia, ...
Liver International 43 (12), 2762-2775, 2023
72023
系统目前无法执行此操作,请稍后再试。
文章 1–20